Gary Jacob
Chief Executive Officer at OKYO PHARMA LIMITED
Net worth: 69 134 $ as of 2024-05-30
Gary Jacob active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Director/Board Member | 2020-12-22 | - |
| Independent Dir/Board Member | 2020-12-22 | - | |
| OKYO PHARMA LIMITED | Director/Board Member | 2021-01-06 | - |
| Chief Executive Officer | 2021-01-06 | - |
Career history of Gary Jacob
Former positions of Gary Jacob
| Companies | Position | Start | End |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Director/Board Member | 2013-05-14 | 2014-03-18 |
| Chief Executive Officer | 2013-05-14 | 2014-03-18 | |
| Chairman | 2014-03-18 | 2024-02-19 | |
| Independent Dir/Board Member | 2014-03-18 | 2024-02-19 | |
| President | 2013-05-14 | 2014-03-18 | |
| VIRPAX PHARMACEUTICALS, INC. | Director/Board Member | 2020-04-27 | 2022-07-24 |
| Independent Dir/Board Member | 2020-04-27 | 2022-07-24 | |
| IMMURON LIMITED | Director/Board Member | 2019-04-16 | 2020-03-24 |
| Chief Executive Officer | 2018-11-15 | 2020-03-24 | |
| SYNERGY PHARMACEUTICALS INC | Director/Board Member | 2011-03-28 | 2014-05-04 |
| Chief Executive Officer | 2008-06-30 | 2017-12-18 | |
| Chairman | 2014-05-04 | 2017-12-31 | |
| Founder | - | 2017-12-31 | |
| Investor Relations Contact | 2011-03-28 | 2014-05-05 | |
| Public Communications Contact | 2011-08-23 | 2014-05-05 | |
| President | 2008-06-30 | 2017-12-18 | |
| Synergy Pharmaceuticals, Inc. /Old/ | Chief Executive Officer | 2008-06-30 | 2017-09-30 |
| Chairman | 2013-08-31 | 2017-09-30 | |
| Founder | 2008-06-30 | 2017-09-30 | |
| President | 2008-06-30 | 2017-09-30 | |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Director/Board Member | 2003-04-30 | 2013-01-21 |
| Chief Executive Officer | 2003-04-30 | 2013-01-21 | |
| Chief Tech/Sci/R&D Officer | 2003-04-30 | 2013-01-21 | |
| Public Communications Contact | 2003-04-30 | 2013-01-21 | |
| President | 2003-12-31 | 2013-01-21 | |
| Pawfect Foods, Inc. | Director/Board Member | 2008-08-10 | 2008-08-10 |
| President | - | 2008-08-10 | |
| ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Gary Jacob
| University of Wisconsin | Doctorate Degree |
| University of Missouri-St. Louis | Undergraduate Degree |
Statistics
International
| United States | 14 |
| United Kingdom | 3 |
| Australia | 2 |
Operational
| Director/Board Member | 9 |
| Chief Executive Officer | 6 |
| President | 5 |
Sectoral
| Health Technology | 10 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| IMMURON LIMITED | Health Technology |
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| Private companies | 7 |
|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Synergy Pharmaceuticals, Inc. /Old/ | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
| Synergy DE | |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
| G.D. Searle LLC |
- Stock Market
- Insiders
- Gary Jacob
- Experience
